Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / June / Virtual Staining and the Next Era of Pathology
Biochemistry and molecular biology Bioinformatics Digital and computational pathology Microscopy and imaging Precision medicine Technology and innovation Digital Pathology

Virtual Staining and the Next Era of Pathology

How AI enables scalable biomarker analysis that preserves tissue samples, addressing some of the most persistent bottlenecks in clinical care and research

By Kenneth To 06/19/2026 Learning 4 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Quiz
  • Top Institutions
  • Topic Commentary

Share

Clinical Report: Virtual Staining and the Next Era of Pathology

Overview

Virtual staining enhances biomarker analysis by providing spatially resolved maps at the individual cell level.

Background

The evolution of pathology practice has necessitated a shift from traditional morphologic diagnosis to a more integrated approach that includes molecular findings and biomarker analysis. Current workflows often struggle with the limitations of physical staining techniques, which can delay clinical decisions and complicate research efforts. Virtual staining offers a solution by leveraging computational models to enhance the analysis of tissue samples.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Virtual staining enhances biomarker analysis by providing spatially resolved representations of expression across tissue sections.
  • This method allows pathologists to identify the presence of biomarkers and their specific cellular contexts.
  • Traditional immunohistochemistry (IHC) can introduce variability and consume valuable tissue, which virtual staining aims to mitigate.
  • AI models have shown promise in predicting biomarker status from H&E images, but often lack the granularity of virtual staining.
  • Virtual staining aligns with pathologists' interpretative methods, focusing on morphology and spatial relationships.

Clinical Implications

The adoption of virtual staining could streamline pathology workflows, reducing turnaround times for critical biomarker analysis. By providing detailed insights into biomarker expression, this approach may enhance decision-making in clinical settings and research.

Conclusion

Virtual staining offers a method for biomarker analysis that aligns with modern clinical needs.

Related Resources & Content

  1. the pathologist, The End of Staining as We Know It?, 2026 -- A new study in Light: Advanced Manufacturing reports a compact optical device that could support faster, label-free tissue analysis in histopathology.
  2. the pathologist, Virtual Staining in the Tumor Microenvironment, 2026 -- Multiplex immunofluorescence can provide rich spatial and phenotypic information for characterizing the tumor microenvironment.
  3. Advancements in Histopathology: Embracing Digital and 3D Technologies Over Traditional Slides, 2018 -- Recent developments in the field of digital pathology urge many pathology departments to digitize slides.
  4. Interpretive Diagnostic Error Reduction, College of American Pathologists -- Updated guidelines acknowledge evolving practice environments and the adoption of digital tools.
  5. A systematic review of machine learning for digital stain processing in pathology, ScienceDirect -- Summarizes approaches for virtual staining and related tasks.
  6. the pathologist — The Future of Subspecialization in Pathology
  7. Interpretive Diagnostic Error… | College of American Pathologists
  8. A systematic review of machine learning for digital stain processing in pathology - ScienceDirect
  9. Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Kenneth To

Kenneth To is co-founder and CEO of ViewsML and a serial entrepreneur with more than 20 years of experience spanning medical affairs, commercialization, product and organizational strategy, and financing. He previously co-founded Wax-it Histology Services and has held leadership roles at STEMCELL Technologies and Eli Lilly and Company, where he led strategy, capability development, and key opinion leader engagement fortheir global medical affairs organization. He holds a PhD in Neuroscience from University of British Columbia and an MBA from Simon Fraser University.

More Articles by Kenneth To

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Patient Is More Than a Price Tag
Bioinformatics
A Patient Is More Than a Price Tag

November 17, 2016

1 min read

In patients with intellectual and metabolic differences, genome-wide sequencing can provide diagnoses and even potential routes to treatment

This Time, It’s Personal
Bioinformatics
This Time, It’s Personal

October 25, 2022

5 min read

Overcoming lung cancer treatment resistance will require predictive biomarkers that take into account significant patient variability

Sepsis Patient Risk Scores
Bioinformatics
A Calculated Risk

February 15, 2023

2 min read

How a personalized sepsis score aims to better stratify patients with acute infection

The Google Genome
Bioinformatics
The Google Genome

November 17, 2014

1 min read

The tech giant’s newest “moonshot” aims to create a complete genomic picture of the healthy human being

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.